179 related articles for article (PubMed ID: 26858337)
1. Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database.
Cheung WY; Renfro LA; Kerr D; de Gramont A; Saltz LB; Grothey A; Alberts SR; Andre T; Guthrie KA; Labianca R; Francini G; Seitz JF; O'Callaghan C; Twelves C; Van Cutsem E; Haller DG; Yothers G; Sargent DJ
J Clin Oncol; 2016 Apr; 34(11):1182-9. PubMed ID: 26858337
[TBL] [Abstract][Full Text] [Related]
2. Nomogram Predicting Survival After Recurrence in Patients With Stage I to III Colon Cancer: A Nationwide Multicenter Study.
Kawai K; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Sugihara K; Watanabe T
Dis Colon Rectum; 2018 Sep; 61(9):1053-1062. PubMed ID: 30086054
[TBL] [Abstract][Full Text] [Related]
3. ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer.
Renfro LA; Grothey A; Xue Y; Saltz LB; André T; Twelves C; Labianca R; Allegra CJ; Alberts SR; Loprinzi CL; Yothers G; Sargent DJ;
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25359867
[TBL] [Abstract][Full Text] [Related]
4. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Meyerhardt JA; Heseltine D; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Thomas J; Nelson H; Whittom R; Hantel A; Schilsky RL; Fuchs CS
J Clin Oncol; 2006 Aug; 24(22):3535-41. PubMed ID: 16822843
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
Dignam JJ; Polite BN; Yothers G; Raich P; Colangelo L; O'Connell MJ; Wolmark N
J Natl Cancer Inst; 2006 Nov; 98(22):1647-54. PubMed ID: 17105987
[TBL] [Abstract][Full Text] [Related]
7. Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.
Ganly I; Amit M; Kou L; Palmer FL; Migliacci J; Katabi N; Yu C; Kattan MW; Binenbaum Y; Sharma K; Naomi R; Abib A; Miles B; Yang X; Lei D; Bjoerndal K; Godballe C; Mücke T; Wolff KD; Fliss D; Eckardt AM; Chiara C; Sesenna E; Ali S; Czerwonka L; Goldstein DP; Gil Z; Patel SG
Eur J Cancer; 2015 Dec; 51(18):2768-76. PubMed ID: 26602017
[TBL] [Abstract][Full Text] [Related]
8. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
Meyerhardt JA; Niedzwiecki D; Hollis D; Saltz LB; Hu FB; Mayer RJ; Nelson H; Whittom R; Hantel A; Thomas J; Fuchs CS
JAMA; 2007 Aug; 298(7):754-64. PubMed ID: 17699009
[TBL] [Abstract][Full Text] [Related]
9. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
[TBL] [Abstract][Full Text] [Related]
10. Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).
Cheng E; Ou FS; Ma C; Spiegelman D; Zhang S; Zhou X; Bainter TM; Saltz LB; Niedzwiecki D; Mayer RJ; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Giovannucci EL; Van Blarigan EL; Brown JC; Ng K; Gross CP; Meyerhardt JA; Fuchs CS
J Clin Oncol; 2022 Mar; 40(7):740-751. PubMed ID: 34995084
[TBL] [Abstract][Full Text] [Related]
11. Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.
Shah MA; Renfro LA; Allegra CJ; André T; de Gramont A; Schmoll HJ; Haller DG; Alberts SR; Yothers G; Sargent DJ
J Clin Oncol; 2016 Mar; 34(8):843-53. PubMed ID: 26811529
[TBL] [Abstract][Full Text] [Related]
12. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
13. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
[TBL] [Abstract][Full Text] [Related]
14. Individualized prediction of colon cancer recurrence using a nomogram.
Weiser MR; Landmann RG; Kattan MW; Gonen M; Shia J; Chou J; Paty PB; Guillem JG; Temple LK; Schrag D; Saltz LB; Wong WD
J Clin Oncol; 2008 Jan; 26(3):380-5. PubMed ID: 18202413
[TBL] [Abstract][Full Text] [Related]
15. A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer.
Margalit O; Mamtani R; Yang YX; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
Eur J Cancer; 2018 Jun; 96():105-110. PubMed ID: 29698932
[TBL] [Abstract][Full Text] [Related]
16. Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer.
Segelman J; Akre O; Gustafsson UO; Bottai M; Martling A
Colorectal Dis; 2014 May; 16(5):359-67. PubMed ID: 24410859
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer.
Mayanagi S; Kashiwabara K; Honda M; Oba K; Aoyama T; Kanda M; Maeda H; Hamada C; Sadahiro S; Sakamoto J; Saji S; Yoshikawa T
Dis Colon Rectum; 2018 Jul; 61(7):803-808. PubMed ID: 29561282
[TBL] [Abstract][Full Text] [Related]
18. Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†.
Renfro LA; Grothey A; Kerr D; Haller DG; André T; Van Cutsem E; Saltz L; Labianca R; Loprinzi CL; Alberts SR; Schmoll H; Twelves C; Yothers G; Sargent DJ;
Ann Oncol; 2015 May; 26(5):950-958. PubMed ID: 25697217
[TBL] [Abstract][Full Text] [Related]
19. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
[TBL] [Abstract][Full Text] [Related]
20. Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.
Sargent DJ; Shi Q; Gill S; Louvet C; Everson RB; Kellner U; Clancy TE; Pipas JM; Resnick MB; Meyers MO; Wu TT; Huntsman D; Validire P; Farooq U; Pavey ES; Beaudry G; Haince JF; Fradet Y
Clin Cancer Res; 2014 Aug; 20(16):4361-9. PubMed ID: 24919572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
